David J. Holland

David J. Holland

Auto-generated profile, based on publicly available information

David J. Holland

School of Medicine, The University of Queensland, Brisbane, Australia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Progress in Cardiovascular Diseases
Verified
Journal Article
Closed access
JTJenna L Taylor
Jenna L Taylor
DHDavid J. Holland
David J. Holland
JSJemima G. Spathis
Jemima G. Spathis
KBKassia S. Beetham
Kassia S. Beetham
UWUlrik Wisløff
Ulrik Wisløff
JCJeff S. Coombes
Jeff S. Coombes

1 October 2013 in JACC
Verified
Journal Article
Closed access
WKWojciech Kosmala
Wojciech Kosmala
DHDavid J. Holland
David J. Holland
ARAleksandra Rojek
Aleksandra Rojek
LWLeah Wright
Leah Wright
MPMonika Przewlocka-Kosmala
Monika Przewlocka-Kosmala
TMThomas H. Marwick
Thomas H. Marwick

2 May 2015 in Heart
Verified
Journal Article
Closed access
PDF file
DHDavid J Holland
David J Holland
TMThomas H Marwick
Thomas H Marwick
BHBrian A Haluska
Brian A Haluska
RLRodel Leano
Rodel Leano
MHMatthew D Hordern
Matthew D Hordern
TSTony Stanton
Tony Stanton
Objective New imaging techniques have permitted the detection of subclinical LV dysfunction (LVD) in up to half of patients with type 2 diabetes mellitus (DM) with a normal EF. However, the connection between early LVD and prognosis is unclear. This study aimed to define the long-term outcome of LVD associated with type 2 DM. Methods In this prospective cohort study, 230 asymptomatic patients with type 2 DM underwent measurement of global longitudinal 2D strain (GLS) for detection of LVD and were followed for up to 10 years. All subjects had normal EF (≥50%) and no evidence of coronary artery disease at recruitment. Outcome data were obtained through centralised state-wide death and hospital admission registries. The primary endpoint was all-cause mortality and hospitalisation. Results On study entry, almost half (45%) of the cohort had evidence of LVD as detected by GLS. Over a median follow-up of 7.4±2.6 years (range 0.6–9.7 years), 68 patients (30%) met the primary endpoint (LVD: 37%; normal LV function: 24%). GLS was independently associated with the primary endpoint (HR=1.10; p=0.04), as was systolic blood pressure (HR=1.02; p<0.001) and levels of glycosylated haemoglobin (HR=1.28; p=0.011). Patients with LVD had significantly worse outcome than those without (χ2=4.73; p=0.030). Conclusions Subclinical LVD is common in asymptomatic patients with type 2 DM, is readily detectable by GLS imaging and is independently associated with adverse outcome. Trial registration number Australian and New Zealand Clinical Trials Registry (ACTRN12612001178831).

1 April 2011 in JACC
Verified
Journal Article
Closed access
DHDavid J. Holland
David J. Holland
DKDharam J. Kumbhani
Dharam J. Kumbhani
SASalim H. Ahmed
Salim H. Ahmed
TMThomas H. Marwick
Thomas H. Marwick

1 March 2010 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
DHDavid J. Holland
David J. Holland
SPSandhir B. Prasad
Sandhir B. Prasad
TMThomas H. Marwick
Thomas H. Marwick
Background— The estimation of left ventricular (LV) filling pressure from the ratio of transmitral and annular velocities (E/e′) after exercise echocardiography may identify diastolic dysfunction in patients who complain of exertional dyspnea. This study sought to determine the relative contributions of exercise E/e′ and ischemia to outcomes in patients referred for exercise echocardiography. Methods and Results— Rest and exercise E/e′ were obtained in 522 patients referred for exercise echocardiography, who were followed for cardiovascular death and hospitalization over a median of 13.2 months. Exercise E/e′ >2 SD from normal was used to denote raised LV filling pressure with stress (n=75), and ischemia (n=250) was identified by inducible wall motion abnormalities. There were 65 cardiovascular hospitalizations during the follow-up period. Survival analysis showed patients without ischemia and with normal exercise E/e′ to have a better prognosis than those with ischemia, with or without raised exercise E/e′ ( P =0.003) and the outcomes of patients with isolated raised exercise E/e′ and isolated ischemia to be similar. Exercise E/e′ was most valuable in patients with normal resting E/e′; those with elevation with exercise had a worse outcome than those with normal exercise E/e′ ( P =0.014). Exercise capacity (hazard ratio, 0.893; P =0.008), exercise wall motion score index (hazard ratio, 1.507; P 14.5 (hazard ratio, 2.988; P =0.002) were independent predictors of outcome. The addition of exercise E/e′ to exercise capacity and wall motion score index resulted in an increment in model power to predict adverse outcome ( P =0.006). Conclusions— Exercise E/e′ is associated with cardiovascular hospitalization, independent of and incremental to inducible ischemia.

1 December 2012 in International Journal of Cardiology
Verified
Journal Article
Closed access
RTRod S. Taylor
Rod S. Taylor
EDEdward J. Davies
Edward J. Davies
HDHasnain M. Dalal
Hasnain M. Dalal
RDRussell Davis
Russell Davis
PDPatrick Doherty
Patrick Doherty
NSNeil A. Smart
Neil A. Smart